Scholarlink

<p>The incidence of ischemic stroke, involving neuronal cell death and damaged blood vessels, is gradually increasing. In this study, we investigated the effects of a miR-495-3p-I on neuronal viability and recovery using both oxygen–glucose deprivation and recovery (OGD/R) and in transient middle cerebral artery occlusion (tMCAo) models of ischemic stroke. Cell viability increased with miR-495-3p-I treatment compared with the OGD/R group, and both early and late apoptosis decreased through by flow cytometry analysis. In the tMCAo model, tissues injected with miR-495-3p-I showed upregulation of canonical Wnt pathway genes (cyclin D1 and c-Myc) and neuronal marker (Tuj1), while non-canonical Wnt/MAPK pathway genes (caspase-3 and -7) were downregulated. Expression of the pro-apoptotic marker Bax was reduced, whereas the Bcl-2 family protein Mcl-1 increased. Behavioral tests revealed improved motor function compared to the sham group and treatment with miR-495-3p-I reduced brain infarct volume. This research explored the function of miR-495-3p-I in Wnt and MAPK pathways by using the miR-495-3p-I in a model of ischemic stroke, a neurological disease. Thus, we demonstrated that miR-495-3p-I reduced apoptosis and enhanced neuronal cell survival, suggesting it could be a potential therapeutic target.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

miR-495-3p Attenuates Neuronal Apoptosis Through The Activation of Wnt/MAPK Pathways in Ischemic Stroke

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月3日

查看全文
  • Eunjae Jang,
  • Hee Yu,
  • Jiyun Choi,
  • Jin Yoo,
  • Hyong-Ho Cho,
  • Byeong C. Kim,
  • Han-Seong Jeong,
  • Sujeong Jang

摘要

The incidence of ischemic stroke, involving neuronal cell death and damaged blood vessels, is gradually increasing. In this study, we investigated the effects of a miR-495-3p-I on neuronal viability and recovery using both oxygen–glucose deprivation and recovery (OGD/R) and in transient middle cerebral artery occlusion (tMCAo) models of ischemic stroke. Cell viability increased with miR-495-3p-I treatment compared with the OGD/R group, and both early and late apoptosis decreased through by flow cytometry analysis. In the tMCAo model, tissues injected with miR-495-3p-I showed upregulation of canonical Wnt pathway genes (cyclin D1 and c-Myc) and neuronal marker (Tuj1), while non-canonical Wnt/MAPK pathway genes (caspase-3 and -7) were downregulated. Expression of the pro-apoptotic marker Bax was reduced, whereas the Bcl-2 family protein Mcl-1 increased. Behavioral tests revealed improved motor function compared to the sham group and treatment with miR-495-3p-I reduced brain infarct volume. This research explored the function of miR-495-3p-I in Wnt and MAPK pathways by using the miR-495-3p-I in a model of ischemic stroke, a neurological disease. Thus, we demonstrated that miR-495-3p-I reduced apoptosis and enhanced neuronal cell survival, suggesting it could be a potential therapeutic target.